Bruush Oral Care Inc. Common Stock
BRSH
BRSH was delisted on the 27th of June, 2024.
3 hedge funds and large institutions have $42K invested in Bruush Oral Care Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.
9% more capital invested
Capital invested by funds: $38.5K → $42K (+$3.51K)
0% more funds holding
Funds holding: 3 → 3 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$72.8K |
| 2 |
HF
HRT Financial
New York
|
+$47.1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$346 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$19.5K |
| 2 |
VF
Virtu Financial
New York
|
-$19K |
BRSH Hedge Fund Activity: Q3 2023 in Review
3 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Bruush Oral Care Inc. Common Stock (BRSH) for Q3 2023, worth a combined $42K — up 9.1% from $38.5K a quarter earlier.
Fund positioning in BRSH was balanced in Q3 2023: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $72.8K. The largest seller was Citadel Advisors, exiting entirely with an estimated $19.5K sold.
- 3 institutional investors held Bruush Oral Care Inc. Common Stock (BRSH) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $42K of Bruush Oral Care Inc. Common Stock stock for Q3 2023, up 9.1% quarter-over-quarter.
- 2 funds opened new Bruush Oral Care Inc. Common Stock positions in Q3 2023 and 2 closed out, a net change of 0 holders.
- The largest Bruush Oral Care Inc. Common Stock buyer in Q3 2023 was Two Sigma Securities, an estimated $72.8K added.
- The largest Bruush Oral Care Inc. Common Stock seller in Q3 2023 was Citadel Advisors, an estimated $19.5K sold.
Based on aggregated 13F filings for Q3 2023.